Automated Compounding Systems Market to Grow at a CAGR of 7.0% to reach US$ 684.17 Mn Million from 2020 to 2027

Automated Compounding Systems Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product Type (Gravimetric Automated Compounding Systems and Volumetric Automated Compounding Systems); End User (Hospitals, Chemotherapy Centers, and Others) and Geography

  • Report Code : TIPRE00010169
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 165
Buy Now

The automated compounding systems market was valued at US$ 403.88 million in 2019 and is projected to reach US$ 684.17 million by 2027; it is expected to grow at a CAGR of 7.0% during 2020–2027.

An automated compounding system is a device that combines one or more drug solutions to a final container for patient administration. Automated compounding system helps avoid medication error that occurs due to a variety of factors such as poor management communication between the physician and pharmacist, critical storage practices in pharmacies, and confusion while using similar labels. However, with the automated compounding systems, the accuracy and efficiency of dispensing compounded products have improved and reduced the exposure of healthcare professionals to toxic agents. The global automated compounding systems market is driven by factors such as the growing adoption of chemotherapy and personalized medication, rising need to minimize medication errors. However, the high cost of automated compounding systems will impede the market growth. Furthermore, increasing awareness in pharmacists is likely to offer significant opportunities for the growth of the global automated compounding systems market

Lucrative Regional Automated Compounding Systems markets

Lucrative Regional Automated Compounding Systems markets
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Market Insights

Growing Adoption of Chemotherapy and Personalized Medication

Cancer is a shattering disease that causes significant number of deaths every year. Due to disease heterogeneity, standard cures such as chemotherapy or radiation are an efficient solution as a treatment among the patient population. Chemotherapy is a drug therapy that needs powerful chemicals to eliminate fast-multiplying tumor cells in the body. Chemotherapy is most often used to treat malignancy, as the cancer cells grow and increase rapidly compared to other cells in the body.

The rapid adoption of novel therapies, such as chemotherapy, in oncology has been reported to provide better treatment options for breast, lung, and prostate cancers. Similarly, the area of precision and personalized medicine (PPM) is developed to make therapies for a single patient or specific groups based on data that captures current and past physical health and environmental experience. Recently, several reports show that the assimilation of PPM viewpoint into cancer research and treatment will result in significant enhancements in fighting cancer, mainly due to its complexity and interpatient unpredictability.

Several manufactures offer automated compounding systems toward chemotherapy and personalized medicines. For instance, Pharmoduct (Comecer) is an automated device used for the sterilized preparation of personalized oncology drugs, which includes chemotherapy and biologicals.

Products Insights

The gravimetric automated compounding systems held the largest share in the global automated compounding systems market. The growth of the segment is attributed to the increasing adoption of this method for the preparation of IV agents such as antineoplastic agents, along with the reduction of potential errors. Also, the well-known players in this market are using gravimetric techniques in automation compounding systems. For instance, fully automated compounding systems, such as RIVA, use precise automated measuring methods and gravimetric checks to ensure the accuracy of each dose.

Global Automated Compounding Systems market, by Product Type– 2019& 2027

Global Automated Compounding Systems market, by Product Type– 2019& 2027
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

End User Insights

Based on end user, the automated compounding systems market is segmented into hospitals, chemotherapy centers, and others. The hospitals segment held the largest share in the global automated compounding systems market in 2019. Growth of the segment is attributed to exposure to global trends, increasing medication errors, and the need to provide the highest standards of patient care. For instance, some studies have observed that the standard error rates of up to 10% in hospital pharmacies. As a result, ensuring the safety of compounded medications and the control of quality and cost of IV therapy has been a priority for hospitals. That is why automated compounding systems are considered to be an essential component of safe and efficient pharmacy operations. Moreover, strategic initiatives by the major players are likely to augment the segmental growth in coming years. For instance, Omnicell announced that Allegheny General Hospital, Pittsburgh, Pa., part of Allegheny Health Network (AHN), has collaborated with Omnicell for in sourcing Central Pharmacy IV Compounding Service.

As hospitals recognize the need to provide the highest standards of patient care, the demand for automated compounding systems is likely to increase at a steady pace during the forecast period.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Automated Compounding Systems Market: Strategic Insights

automated-compounding-systems-market
Market Size Value inUS$ 403.88 Million in 2019
Market Size Value byUS$ 684.17 Million by 2027
Growth rateCAGR of 7.0% from 2020-2027
Forecast Period2020-2027
Base Year2020
Analyst Image

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Collaborations and technology partnerships by the operating players in the market to bridge the demand-supply gap is anticipated to play a significant role in the growth of the automated compounding systems industry during the forecast period. Moreover, the rising need to minimize medication errors predicted to accelerate market growth.

By Product Type

  • Gravimetric Automated Compounding Systems
  • Volumetric Automated Compounding Systems

By End User

  • Hospitals
  • Chemotherapy Centers
  • Others

By Geography

  • North America

    • US
    • Canada
    • Mexico
  • Europe

    • France
    • Germany
    • Italy
    • UK
    • Russia
    • Rest of Europe
  • Asia Pacific (APAC)

    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of Asia Pacific
  • Middle East & Africa (MEA)

    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of Middle East and Africa
  • South America

    • Brazil
    • Argentina
    • Rest of South America

Company Profiles

  • Baxter International Inc.
  • Braun Melsungen AG
  • Comecer
  • ICU MEDICAL INC
  • Grifols, S.A.
  • OMNICELL INC.
  • EQUASHIELD
  • ARxIUM
  • Weibond Technology
  • NewIcon
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Product Type ; End User and Geography

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

Frequently Asked Questions


What are the automated compounding systems?

An automated compounding system is a device that combines one or more drug solutions to a final container for patient administration. Automated Compounding System helps avoid medication error that occurs due to a variety of factors such as poor management communication between the physician and pharmacist, critical storage practices in pharmacies, and confusion that was arising out of the use of similar labels.

What are the driving factors for the automated compounding systems market across the globe?

The global automated compounding systems market is being driven by factors such as the growing adoption of chemotherapy and personalized medication, rising need to minimize medication errors. Furthermore, increasing awareness in pharmacists is likely to offer significant opportunities for the growth of the global automated compounding systems.

What are the restraining factors for the automated compounding systems market across the globe?

The high cost of the automated compounding systems is the significant factor that will impede the automated compounding systems market growth. Automated compounding systems have been introduced to the healthcare sector more than a decade ago, but only a few pharmacies use them. The high cost of the devices is one of the significant factors for the hindrance of market growth. Also, disadvantages of automated preparation are the danger of failure/downtime, dependence on the power supply, software (updates), high venture and high maintenance costs, dedicated personnel with extra training, declined worker satisfaction, complication when products are exchanged or added.

The List of Companies - Automated Compounding Systems Market

  1. Baxter International Inc.
  2. Braun Melsungen AG
  3. Comecer
  4. ICU MEDICAL INC
  5. Grifols, S.A.
  6. OMNICELL INC.
  7. EQUASHIELD
  8. ARxIUM
  9. Weibond Technology
  10. NewIcon

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Automated Compounding Systems Market